All Insights
Court of Appeal judge provides obiter guidance on the correct application of Formstein defence in the UK
The decision provides a further example that the UK courts are likely to accept the Formstein defence, when required, and
Car wars: how tech ownership battles will decide the future leaders of autonomous vehicles
An upsurge in patent filings by new competitors in the autonomous vehicles arena means incumbents need to strengthen their IP
Debate intensifies over a vaccine IP waiver's impact on future pharma and biotech discoveries
Does a proposed patent suspension backed by Washington open a Pandora's box for vaccine R&D and investment?
The future of the construction industry: offsite construction, next-generation connectivity and artificial intelligence
In this Sector note, Osborne Clarke LLP discuss how new and emerging technologies (such as next general connectivity and artificial
Patents Court upholds validity of second medical use patent for glaucoma treatment
This decision shows the court assessing patentability in a real-world practical context, recognising the uncertainties of R&D that only later
EPO Decision G1/19 on patenting computer simulations
In its decision of 10 March 2021, the Enlarged Board of Appeal (EBA) of the European Patent Office (EPO) ruled
Patents Court offers guidance on use of doctrine of equivalents
Decision makes it clear that a patentee must consider their infringement position at an early stage in proceedings
Where next for intellectual property protection and artificial intelligence in the UK?
The government's recent response to views on the implications of AI for IP policy highlights the need to consider protections
Can gene-editing help solve the energy crisis?
What role can biofuels play in fighting climate change and can CRISPR sequencing technology help it reach its potential?
Battery technology advances are powering the rapid rise of electric vehicles
Patents filed, research and investment are undergoing sustained growth, which is reducing costs in an increasingly mature market